Melanie Büssgen

7PUBLICATIONS
0CO-AUTHORS
Panel data analysisPharmacogenomicsMolecular targetsMajor global burdens of diseaseEconomic development policy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 02, 2023
Authors' Reply to Gandjour: "10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?"

Melanie Büssgen, Tom Stargardt

|Sep 28, 2023
Pipeline progress and portfolio management of the top 30 pharma companies over the past two decades.

Melanie Büssgen, Marcel A Büssgen

|Sep 25, 2023
Effectiveness and cost-effectiveness of combination therapy versus monotherapy in malignant melanoma.

Dilay Özdemir, Melanie Büssgen

|Jun 19, 2023
Does health technology assessment compromise access to pharmaceuticals?

Melanie Büssgen, Tom Stargardt

|May 30, 2023
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?

Melanie Büssgen, Tom Stargardt

|Aug 29, 2022
Indication-wide drug pricing: Insights from the pharma market.

Florian Siegmeier, Melanie Büssgen

Pageof 2

Frequent Collaborators